Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

275.85 +3.44 (+1.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
53 54 Next >
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest. 
Via The Motley Fool
Moderating Inflation, a Tasty IPO, Bull Market Talk, and More
We've also got two stocks worth watching: Chevron and Burford Capital. 
Via The Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment. 
Via The Motley Fool
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today
Via Benzinga
Amgen's Debt Overview
Via Benzinga
Here's How Much $1000 Invested In Amgen 15 Years Ago Would Be Worth Today
Via Benzinga
Amgen Unusual Options Activity For June 01
Via Benzinga
Why AbbVie and Amgen Are Moving Lower Today
An ultra-low-priced biosimilar may negatively impact both biotechs. 
Via The Motley Fool
How to Retire Rich: Biotech Stocks Edition
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks. 
Via InvestorPlace
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A. 
Via Investor's Business Daily
5 Stocks to Buy With Explosive 500% Potential
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential. 
Via InvestorPlace
Is the Biotech Industry (IBB) Poised For A Major Breakout?
The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range. 
Via MarketBeat
Topics ETFs
Is Amgen a Good Dividend Stock?
The biotech's yield is near an all-time high right now. 
Via The Motley Fool
Check Out What Whales Are Doing With AMGN
Via Benzinga
Is AbbVie or Amgen the Better Bargain Buy Right Now?
These elite drugmakers are both working through a number of headwinds. 
Via The Motley Fool
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
This year’s 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023) provided a surprising amount of clinical data relevant to biopharma investors. 
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
The 3 Best Long-Term Dividend Stocks to Buy in June
Build a solid investment portfolio with the best long-term dividend stocks and enjoy passive income for many years to come. 
Via InvestorPlace
Dow Stocks Like Microsoft, Apple, Disney, and Verizon Reveal Two Sides of the Market
Many well-known stocks are missing out on the market's epic 2023 rally. 
Via The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Big Pharma is facing a patent cliff that could siphon off billions in revenue. 
Via Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling. 
Via InvestorPlace
3 Stocks Worth Buying at 52-Week Lows
Here are three stocks that are trading near their 52-week lows and may be primed for a short-term rally for opportunistic investors 
Via MarketBeat
Top-Ranked Dividend Stocks: A Smarter Way To Boost Your Retirement Income
Here are three dividend-paying stocks retirees should consider for their nest egg portfolio. 
Via Talk Markets
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.
Biotech-giant Amgen aims to launch a rival. 
Via The Motley Fool
3 Dogs of the Dow for High-Yield Investors
These Dogs of the Dow boast high dividend yields and will hold up well in a potential recession. Let's take a look. 
Via InvestorPlace
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Should Pfizer and Seagen investors be worried? 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
Pfizer stock surged on its diabetes news this week, but one analyst says there's a key piece missing from the story. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Pfizer's diabetes drug led to faster weight loss than Novo Nordisk's Ozempic. 
Via Investor's Business Daily
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
53 54 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS